Often drug companies will find creative ways to get around FDA regulations concerning drug marketing. Man times, drug companies will pay doctors to promote their drugs, including the “off label” uses.
The FDA does not allow drug manufacturers to market their drugs for unapproved uses. Therefore, drug companies will often pay doctors like Dr. Peter Gleason, a Maryland psychiatrist, to speak at industry conferences. In the case of Dr. Gleason, he has recently been charged with promoting the drug Xyrem for purposes other than those approved by the federal government.
Xyrem is a narcolepsy drug but Dr. Gleason advocated its use in treating depression and for pain relief.
For the full article.